« Previous
Next »
Diagnostic Microbiology & Infectious Disease
Volume 67, Issue 3
, Pages 261-265
, July 2010
High prevalence of extended-spectrum β-lactamases and plasmid-mediated AmpC β-lactamases in Enterobacteriaceae isolated from long-term care facilities in Korea
References
- . First detection of CTX-M-28 in Tunisian hospital from a cefotaxime-resistant Klebsiella pneumoniae strain. Pathol. Biol. 2009;57:343–348
- . Clinical and molecular epidemiology of healthcare-associated infections due to extended-spectrum β-lactamases (ESBL)–producing strains of Escherichia coli and Klebsiella pneumoniae that harbor multiple ESBL genes. Infect. Control Hosp. Epidemiol. 2008;29:1026–1034
- . Multiple antibiotic-resistant bacteria in long-term-care facilities: an emerging problem in the practice of infectious disease. Clin. Infect. Dis. 2000;31:1414–1422
- . Performance standards for antimicrobial susceptibility testing document, M100-S19. Vol. 29. Wayne, PA: CLSI; 2009;
- . Surveillance of community-based reservoirs reveals the presence of CTX-M, imported AmpC, and OXA-30 β-lactamases in urine isolates of Klebsiella pneumoniae and Escherichia coli in a U.S. community. Antimicrob. Agents Chemother. 2008;52:3814–3816
- . Prevalence and types of extended-spectrum β-lactamases among urinary Escherichia coli and Klebsiella spp. in New Zealand. Int. J. Antimicrob. Agents. 2009;34:544–549
- Prevalence of Ambler class A extended-spectrum β-lactamase–producing Escherichia coli and Klebsiella pneumoniae isolates in Korea. Korean J. Clin. Microbiol. 2005;8:17–25
- . CTX-M β-lactamase–producing Escherichia coli in long-term care facilities, France. Emerg. Infect. Dis. 2004;10:1697–1698
- . Sequence analysis of blaCTX-M-28, an ESBL responsible for third-generation cephalosporin resistance in Enterobacteriaceae, for the first time in India. Indian J. Pathol. Microbiol. 2008;51:218–221
- . Prevalence and characterization of extended-spectrum β-lactamase–producing Enterobacteriaceae isolated in Korean hospitals. Diagn. Microbiol. Infect. Dis. 2008;61:453–459
- . Investigation of Klebsiella pneumoniae isolates producing SHV-12 and SHV-11 β-lactamases in Korean hospitals. J. Microbiol. Biotechnol. 2009;19:1065–1069
- . CTX-M: changing the face of ESBLs in Europe. J. Antimicrob. Chemother. 2007;59:165–174
- . Prevalence and risk factors of extended-spectrum beta-lactamase–producing Escherichia coli and Klebsiella pneumoniae in an Israeli long-term care facility. Eur. J. Clin. Microbiol. Infect. Dis. 2005;24:17–22
- . Acquired AmpC type beta-lactamase: an emerging problem in Italian long-term care and rehabilitation facilities. New Microbiol. 2007;30:295–298
- . Extended-spectrum β-lactamases in long-term-care facilities. Clin. Microbiol. Infect. 2008;14:111–116
- . Spread of Escherichia coli strains with high-level cefotaxime and ceftazidime resistance between the community, long-term care facilities, and hospital institutions. J. Clin. Microbiol. 2006;44:2359–2366
- . Detection of plasmid-mediated AmpC β-lactamase genes in clinical isolates by using multiplex PCR. J. Clin. Microbiol. 2002;40:2153–2162
- . Plasmid-determined AmpC-type β-lactamases. Antimicrob. Agents Chemother. 2002;46:1–11
- . Nursing homes as a reservoir of extended-spectrum β-lactamase (ESBL)–producing ciprofloxacin-resistant Escherichia coli. J. Antimicrob. Chemother. 2009;64:635–641
- . Dissemination of SHV-12 and CTX-M–type extended-spectrum β-lactamases among clinical isolates of Escherichia coli and Klebsiella pneumoniae and emergence of GES-3 in Korea. J. Antimicrob. Chemother. 2005;56:698–702
- Society for Healthcare Epidemiology of America and the Infectious Disease Society of America Joint Commission on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Infect. Control Hosp. Epidemiol. 1997;18:275–291
- . A 7-year surveillance for ESBL-producing Escherichia coli and Klebsiella pneumoniae at a university hospital in Taiwan: the increase of CTX-M-15 in the ICU. Epidemiol. Infect. 2009;21:1–11
- . Increasing trend in the prevalence of plasmid-mediated AmpC β-lactamases in Enterobacteriaceae lacking chromosomal ampC gene at a Korean university hospital from 2002 to 2004. Diagn. Microbiol. Infect. Dis. 2006;55:219–224
- . CTX-M-14 and CTX-M-15 enzymes are the dominant type of extended-spectrum β-lactamase in clinical isolates of Escherichia coli from Korea. J. Med. Microbiol. 2009;58:261–266
- . Control of infections due to extended-spectrum β-lactamases–producing organisms in hospitals and the community. Clin. Microbiol. Infect. 2008;14:124–133
- . Resistance of strains producing extended-spectrum β-lactamases and genotype distribution in China. J. Infect. 2007;54:53–57
- . Emergence and wide dissemination of CTX-M–type ESBLs, and CMY-2- and DHA-1–type AmpC β-lactamases in Korean respiratory isolates of Klebsiella pneumoniae. J. Korean Med. Sci. 2005;20:961–965
PII: S0732-8893(10)00048-9
doi: 10.1016/j.diagmicrobio.2010.02.012
© 2010 Elsevier Inc. All rights reserved.
« Previous
Next »
Diagnostic Microbiology & Infectious Disease
Volume 67, Issue 3
, Pages 261-265
, July 2010
